Skip to main content
. 2020 Aug 26;4(9):nzaa143. doi: 10.1093/cdn/nzaa143

TABLE 1.

Outcome and assessment points1

Assessment point
Variable Measure Set 1 Set 2 Set 3
Primary outcomes
 Continuous glucose concentration
  PMG FreeStyle Libre Flash glucose monitoring system
  AUC24
  MAGE
Secondary outcomes
 Lipid metabolism Blood samples
 Inflammation Blood samples
 Oral microbiota Saliva
 Gut microbiota profiling Fecal samples
 Fecal metabolites Fecal samples
 Metabolomics profiling Blood samples
Fecal samples
Urine samples
 Physiological characteristics
  Weight Kubei height scale   √
  Blood pressure YUWELL YE660D upper arm sphygmomanometer   √  √

1AUC24, total area under the continuous glucose monitoring curve from 0:00 to 24:00; MAGE, mean amplitude of glycemic excursions; PMG, postprandial maximum glucose. ● = per day during intervention periods; √ = before and after intervention periods.